Crystalys Therapeutics closes $130M Series B to fund gout drug trials

Go back to Crystalys Therapeutics closes $130M Series B to fund gout drug trials
Fabien Corp (NASDAQ: FBIO) Delayed: 2.50 -0.01 (0.4%)
Previous Close $2.51    52 Week High $4.66 
Open $2.51    52 Week Low $2.01 
Day High $2.52    P/E N/A 
Day Low $2.48    EPS $0.00 
Volume 38,245